Ph.D. Alumni
Year Graduated:
2014
Sequence:
Drug Development
Advisor:
Dr. Hamid Omidian
Dissertation Title:
Design and Analysis of Novel Abuse Deterrent Formulation
Current position:
Pharmacy Operations Supervisor — Sterile Compounding Services, Baptist Hospital of Miami | Baptist Health South Florida
Year Graduated:
2015
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Leanne Lai
Dissertation Title:
Modeling the Cost-Effectiveness of Statin Therapy in Rheumatoid Arthritis. A Markov-Cycle Evaluation from National Data Bank for Rheumatic Diseases
Current position:
Assistant Professor, Director of Student Activities Unit, and Vice-President of Center for Alignment of Educational Outcomes with Labor Market, King AbdulAziz University, Saudi Arabia
Year Graduated:
2015
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Nile Khanfar
Dissertation Title:
Investigating the Impact of Organizational Cynicism & Job Attitudes as Antecedents of Organizational Citizenship Behaviors: An Empirical Study of Chain Community Pharmacists
Current position:
Chairperson, Clinical Pharmacy, GM of the Communication and Information Center (GIC), College of Pharmacy, at King AbdulAziz University, Saudi Arabia
Year Graduated:
2016
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Catherine Harrington
Dissertation Title:
The Association Between Diabetes Mellitus, Use of Glucose Lowering Agents and Cancer Incidence Among Medicare Patients
Current position:
Director of Pharm.D./Bachelor Program, Training Unit Supervisor, College of Pharmacy at King Saud University Saudi Arabia
Year Graduated:
2016
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Leanne Lai
Dissertation Title:
Socioeconomic Factors Associated with Antihyperlipidemic Pharmacotherapy in the United States: Application of the Andersen Behavioral Model
Current position:
Assistant Professor, Prince Satam Bin Abdulaziz University, Saudi Arabia
Year Graduated:
2016
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Leanne Lai
Dissertation Title:
Assessing the Burden of Illness Associated with Anxiety Disorder in Patients with Diabetes Mellitus
Current position:
Assistant Professor, Prince Sattam Bin Abdulaziz University, Saudi Arabia
Year Graduated:
2016
Sequence:
Drug Development
Advisor:
Dr. Hamid Omidian
Dissertation Title:
Design and Analysis of Improved Abuse Deterrent Compositions
Current position:
Product Steward, Manufacturing and Technical Services at Mylan Pharmaceuticals ULC in Morgantown, WV
Year Graduated:
2017
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Silvia Rabionet
Dissertation Title:
Investigating to Antiretroviral Therapy in Patients of Caribbean Descent Living with HIV/AIDS
Current position:
Assistant Professor, Findlay College of Pharmacy
Year Graduated:
2017
Sequence:
Drug Development
Advisor:
Dr. Mutasem Rawas-Qalaji
Dissertation Title:
Formulation and Evaluation of Fast Disintegrating Sublingual Atropine Tablets for the Potential Treatment of Acute Organophosphates Toxicity
Current position:
Assistant Professor, Prince Satam Bin Abdulaziz University, Saudi Arabia
Year Graduated:
2017
Sequence:
Molecular Medicine and Pharmacogenomics
Advisor:
Dr. Jean Latimer
Dissertation Title:
Molecular Regulation of Nucleotide Excision Repair in Breast Cancer and Acute Lymphoblastic Leukemia
Current position:
Assistant Professor, King Saud University, Saudi Arabia
Year Graduated:
2017
Sequence:
Drug Development
Advisor:
Dr. Young M. Kwon
Dissertation Title:
Triggered Delivery of a Thrombolytic Drug for Potential Stroke Therapy
Current position:
Chairman, Pharmaceutics Department, College of Pharmacy, King Saud University, Saudi Arabia
Year Graduated:
2017
Sequence:
Drug Development
Advisor:
Dr. Young M. Kwon
Dissertation Title:
Modulation of Insulin Release from Crystalline Basal Formulations Using Injectable Matrix
Current position:
Assistant Professor, Jazan University, Saudi Arabia
Year Graduated:
2017
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Michelle A. Clark
Dissertation Title:
Pathophysiological Relevance of Astroglial Angiotensin and the Endocannabinoid Signaling Systems in SHRs
Current position:
Postdoctoral fellow, Medical College of Wisconsin
Year Graduated:
2017
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Michelle A. Clark
Dissertation Title:
The Proliferative and Proinflammatory Roles of Angiotensin III in Wistar and SHR Cultured VSMCS
Current position:
Assistant Professor, King Saud University, Saudi Arabia
Year Graduated:
2017
Sequence:
Drug Development
Advisor:
Dr. Hamid Omidian
Dissertation Title:
Improved Abuse Deterrent Compositions
Current position:
Research Scientist at Unipharma, LLC, Florida
Year Graduated:
2017
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Barry Bleidt
Dissertation Title:
Measuring Knowledge and Attitudes Regarding the Use of Pharmacogenetic Testing among Patients and Prescribers: Diffusion of Innovation Theory
Current position:
Assistant Professor, Jordan University of Science and Technology (JUST), Jordan
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Appu Rathinavelu
Dissertation Title:
Preclinical Evaluation of F16 as Novel VEGFR-2 Inhibitor for Cancer Treatment
Current position:
Assistant Professor, King Saud University, Saudi Arabia
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Jean Latimer
Dissertation Title:
Ancestral Dependence on Breast Stemness and Nucleotide Excision Repair in Breast Cancer Stem Cells in Novel Human Model Systems
Current position:
Associate, Program Development at Biorasi (https://www.biorasi.com)
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Jean Latimer
Dissertation Title:
Analysis of Molecular Changes in 2 Types of Non-Tumor Adjacent Breast Identified by Nucleotide Excision Repair in Early Stage Sporadic Breast Cancer
Current position:
Associate Scientist at Genewiz
Year Graduated:
2018
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Barry Bleidt
Dissertation Title:
National-Level Analysis of Inpatient ADEs and Patient-Related Risk Factors: Using the ADE Action Plan's Targets
Current position:
Assistant Professor, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Ana Maria Castejon
Dissertation Title:
Role of Oxidative Stress in Autism: In silico, In vitro and Clinical Studies
Current position:
Project Management at Biorasi
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Michelle A. Clark
Dissertation Title:
Role of βArrestins in Ang II-Mediated Signaling in Rat Brainstem Astrocytes
Current position:
Postdoctoral Fellow, Weizmann Institute
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Ana Maria Castejon
Dissertation Title:
The Proliferative and the Protective Effect of Oxytocin against Apoptosis and Oxidative Stress in U87-MG Cells
Current position:
Assistant Professor, Pharmacology and Toxicology, College of Pharmacy at King Saud University
Year Graduated:
2018
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Appu Rathinavelu
Dissertation Title:
MDM2 Overexpression Promotes Angiogenesis and Metastasis through Dysregulation of MMP-9 and TIMP-1
Current position:
Assistant Professor, Al-Imam Muhammad Ibn Saud Islamic University
Year Graduated:
2018
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Jesus Sanchez
Dissertation Title:
An Exploratory Factor Analysis Model for Restrictiveness in Medicare Part D Prescription Drug Plans
Current position:
Consultant and Adjunct Faculty, Nova Southeastern University
Year Graduated:
2018
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Ioana Popovici
Dissertation Title:
An Economic Evaluation of State Laws Regulating Non-Medical Use of Prescription Opioids in the US
Current position:
Assistant Professor, Jordan University of Science and Technology (JUST), Jordan
Year Graduated:
2018
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Silvia Rabionet
Dissertation Title:
Impact of Antidepressants Use on Healthcare Utilization and Health-Related Quality of Life among Individuals with Type 2 Diabetes and Depression Symptoms
Current position:
Assistant Professor, Princess Nourah bint Abdulrahman University
Year Graduated:
2018
Sequence:
Social and Administrative Pharmacy
Advisor:
Dr. Leanne Lai
Dissertation Title:
Comparative Effectiveness of Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
Current position:
Assistant Professor, King Saud University, Saudi Arabia
Year Graduated:
2019
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Ana Maria Castejon
Dissertation Title:
Protective Actions of Oxytocin on Aortic Vascular Smooth Muscle Cells (VSMCs) from Normotensive (NT) and Hypertensive rats (SHRs)
Current position:
Assistant Professor of Pharmacology, Lake Erie College of Osteopathic Medicine, Erie, PA
Year Graduated:
2019
Sequence:
Drug Development
Advisor:
Dr. Mutasem Rawas-Qalaji
Dissertation Title:
Enhancing the Sublingual Permeability of Atropine Sulfate: Effect of PH and Penetration Enhancers
Current position:
Assistant Professor, Taibah University
Year Graduated:
2019
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Appu Rathinavelu
Dissertation Title:
Cellular and Molecular Regulation of HIF -1α in MDM2 Overexpressed Prostate Cancer Cells
Current position:
Assistant Professor, Department of Pharmacology and Toxicology, King Saud University, Riyadh, Saudi Arabia
Year Graduated:
2019
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Jean Latimer
Dissertation Title:
Analysis of Genomic Instability and Invasiveness in Ductal Carcinoma in Situ
Current position:
Assistant Professor, Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University
Year Graduated:
2019
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Appu Rathinavelu
Dissertation Title:
MDM2 Promotes Epithelial to Mesenchymal Transition and Metastasis of LNCaP Prostate Cancer Cells
Current position:
Post-Doctoral, Stephenson Cancer Center, The University of Oklahoma Health Sciences Cancer Center
Year Graduated:
2019
Sequence:
Molecular Medicine Pharmacogenomics
Advisor:
Dr. Appu Rathinavelu
Dissertation Title:
Evaluation of F16 as a Novel Antiangiogenic Agent for Glioblastoma Treatment
Current position:
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Year Graduated:
2020
Sequence:
Drug Development
Advisor:
Dr. Hamid Omidian
Dissertation Title:
Development and Characterization of Improved Abuse-Deterrent Compositions Based on Crosslinked Anionic Polymers
Current position:
Formulation Scientist II, Hikma Pharmaceuticals